Cytoreductive surgery for metastatic gastrointestinal stromal tumors treated with ripretinib: A single-center experience

Background: Cytoreductive surgery (CRS) has been advocated as an additional treatment with survival benefits for advanced gastrointestinal stromal tumor (GIST), especially in patients with responsive disease or focal progression after treatment with imatinib. Ripretinib is a fourth-line therapy for...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Zhaoming Guan, Shaohua Yang, Kaiyu Sun, Yihang Shi, Yun Feng, Shirong Cai, Xinhua Zhang, Yulong He
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2023-09-01
Schriftenreihe:	Clinical Surgical Oncology
Schlagworte:	Gastrointestinal stromal tumor Ripretinib Cytoreductive surgery
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S2773160X23000119
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!